Argenx to present at the 11th annual svb leerink global healthcare conference

February 10, 2022 breda, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the 11th annual svb leerink global healthcare conference on thursday, february 17, 2022 at 10:40 a.m. et.
ARGX Ratings Summary
ARGX Quant Ranking